Combined electrochemical therapy (CET) an innovative approach to the management of peripheral neuropathy

Neuronium
03/04/2024
last update4 March 2024

Combined electrochemical therapy (CET) offers an innovative approach to the management of peripheral neuropathy, including pain associated with various etiologies. Stay with us in the rest of this article.

1. Neuropathy Basics :

Neuropathy results from pathologic processes gone awry, either due to injury or disease.
The prevalence of peripheral neuropathy is growing, affecting up to 2.4% of the population in the United States.
Morbidity associated with neuropathies represents a significant cost to patients and society¹.

2. The Role of Hypo-Oxygenation :

Neuropathic pain occurs when signaling between adjacent nerve cells weakens due to insufficient oxygen transport .
The hypo-oxidative state associated with neuropathic pain is a primary factor.
Unlike muscles, nerve cells rely solely on the oxidative-reductive metabolic system (Krebs cycle) for energy production¹.

3. Combined Electrochemical Treatment (CET) :

CET combines two essential components:
– Local Anesthetic Blocks : These provide immediate pain relief.
Electric Cell Signaling Treatment (EST) : EST uses rapidly alternating polarity to enhance ion movement, normalize pH, and reduce tissue acidosis.
Under the influence of rapidly alternating polarity, ion movement is enhanced, balancing metabolite concentration and promoting pH normalization.
The combination of local anesthetics and EST effectively treats neuropathies of all causes¹.

4. Reversing the Neuropathic Process :

Clinical observations and objective functional testing demonstrate the reversal of neuropathic processes with CET.
CET impacts both clinical symptoms and objective neurodiagnostic data.
Although formal double-blinded control studies are ongoing, CET shows promise in improving patients’ lives¹.